Digital Health Intervention to Improve TPT Uptake

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorArba Minch University

About this trial

Despite the evidence of the prevention and control measures of tuberculosis (TB), it still has an impact on the health, social, and economic aspects of the population. Specifically, tuberculosis in children and newly diagnosed TB cases show there is current transmission of TB; to reduce this transmission and to attain the end TB strategy, preventing household TB transmission plays a great role. However, initiation and completion of TB preventive therapy (TPT) among close contacts of index TB patients are suboptimal. Some of the identified factors of low TPT initiation and completion are insufficient patient education, inadequate understanding of TPT, health professionals' perception, parental knowledge, and belief. The digital health intervention is currently being studied as a suggested health intervention that improves the utilization of health care services, including treatment adherence. A systematic review shows that TB treatment outcomes improved with the use of patient education, counseling, text reminders, and digital health technologies. However, other literature indicates controversial results, including our systematic review result, which identified that video directly observed therapy and text message (digital intervention) have no significant effect on TPT completion. In addition, the studies are scarce; therefore, this study aims to assess the effect of video-based education intervention combined with text message reminder (digital health intervention) in improving the initiation and completion of TPT among close contacts of drug-sensitive pulmonary TB patients in South Ethiopia.

The study hypothesizes that digital health intervention for close contacts of index drug-sensitive pulmonary TB patients will lead to higher TPT initiation and completion rates than standard care.

Eligibility criteria

Qualifiers

All household and close contacts of drug-sensitive pulmonary TB patients

Living in the catchment area of the selected health facility

Willing to stay for at least 4 months in the catchment area

Disqualifiers

Individuals with a known allergy to TPT drugs or those contraindicated for TPT drugs

Close contacts screened as symptomatic for TB

Close contacts with drug-resistant TB

Temporary residents staying for less than 4 months

Trial design

Treatments tested in this trial

  • Digital health intervention

Treatment groups

304 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators